Literature DB >> 23451707

Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.

Rajesh Karuturi1, Rami A Al-Horani, Shrenik C Mehta, David Gailani, Umesh R Desai.   

Abstract

To discover promising sulfated allosteric modulators (SAMs) of glycosaminoglycan-binding proteins (GBPs), such as human factor XIa (FXIa), we screened a library of 26 synthetic, sulfated quinazolin-4(3H)-ones (QAOs) resulting in the identification of six molecules that reduced the Vmax of substrate hydrolysis without influencing the KM. Mutagenesis of residues of the heparin-binding site (HBS) of FXIa introduced a nearly 5-fold loss in inhibition potency supporting recognition of an allosteric site. Fluorescence studies showed a sigmoidal binding profile indicating highly cooperative binding. Competition with a positively charged, heparin-binding polymer did not fully nullify inhibition suggesting importance of hydrophobic forces to binding. This discovery suggests the operation of a dual-element recognition process, which relies on an initial Coulombic attraction of anionic SAMs to the cationic HBS of FXIa that forms a locked complex through tight interaction with an adjacent hydrophobic patch. The dual-element strategy may be widely applicable for discovering SAMs of other GBPs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23451707      PMCID: PMC3625964          DOI: 10.1021/jm301757v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  55 in total

1.  Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinones.

Authors:  Y Xia; Z Y Yang; M J Hour; S C Kuo; P Xia; K F Bastow; Y Nakanishi; P Namrpoothiri; T Hackl; E Hamel; H K Lee
Journal:  Bioorg Med Chem Lett       Date:  2001-05-07       Impact factor: 2.823

2.  Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity.

Authors:  Stéphane Sarrazin; David Bonnaffé; André Lubineau; Hugues Lortat-Jacob
Journal:  J Biol Chem       Date:  2005-09-09       Impact factor: 5.157

3.  Synthesis and in vitro biological evaluation of aryl boronic acids as potential inhibitors of factor XIa.

Authors:  Tsvetelina I Lazarova; Lei Jin; Michael Rynkiewicz; Joan C Gorga; Frank Bibbins; Harold V Meyers; Robert Babine; James Strickler
Journal:  Bioorg Med Chem Lett       Date:  2006-07-28       Impact factor: 2.823

4.  Rapid and efficient microwave-assisted synthesis of highly sulfated organic scaffolds.

Authors:  Arjun Raghuraman; Muhammad Riaz; Michael Hindle; Umesh R Desai
Journal:  Tetrahedron Lett       Date:  2007-09-17       Impact factor: 2.415

5.  Polysulfated xanthones: multipathway development of a new generation of dual anticoagulant/antiplatelet agents.

Authors:  Marta Correia-da-Silva; Emília Sousa; Bárbara Duarte; Franklim Marques; Félix Carvalho; Luís M Cunha-Ribeiro; Madalena M M Pinto
Journal:  J Med Chem       Date:  2011-07-18       Impact factor: 7.446

Review 6.  Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.

Authors:  Steven T Olson; Benjamin Richard; Gonzalo Izaguirre; Sophia Schedin-Weiss; Peter G W Gettins
Journal:  Biochimie       Date:  2010-06-02       Impact factor: 4.079

7.  Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.

Authors:  Rami A Al-Horani; Aiye Liang; Umesh R Desai
Journal:  J Med Chem       Date:  2011-08-12       Impact factor: 7.446

8.  Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.

Authors:  A Yacobi; J A Udall; G Levy
Journal:  Clin Pharmacol Ther       Date:  1976-05       Impact factor: 6.875

9.  Clavatadine A, a natural product with selective recognition and irreversible inhibition of factor XIa.

Authors:  Malcolm S Buchanan; Anthony R Carroll; Deborah Wessling; Michael Jobling; Vicky M Avery; Rohan A Davis; Yunjiang Feng; Yafeng Xue; Linda Oster; Tomas Fex; Johanna Deinum; John N A Hooper; Ronald J Quinn
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

Review 10.  Interactions between heparan sulfate and proteins: the concept of specificity.

Authors:  Johan Kreuger; Dorothe Spillmann; Jin-ping Li; Ulf Lindahl
Journal:  J Cell Biol       Date:  2006-07-31       Impact factor: 10.539

View more
  18 in total

1.  Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.

Authors:  Rami A Al-Horani; David Gailani; Umesh R Desai
Journal:  Thromb Res       Date:  2015-04-22       Impact factor: 3.944

2.  A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding.

Authors:  Rami A Al-Horani; Elsamani I Abdelfadiel; Daniel K Afosah; Shravan Morla; Jyothi C Sistla; Bassem Mohammed; Erika J Martin; Masahiro Sakagami; Donald F Brophy; Umesh R Desai
Journal:  J Thromb Haemost       Date:  2019-09-10       Impact factor: 5.824

3.  Inhibition of Herpes Simplex Virus-1 Entry into Human Cells by Nonsaccharide Glycosaminoglycan Mimetics.

Authors:  Rahaman Navaz Gangji; Nehru Viji Sankaranarayanan; James Elste; Rami A Al-Horani; Daniel K Afosah; Rachel Joshi; Vaibhav Tiwari; Umesh R Desai
Journal:  ACS Med Chem Lett       Date:  2018-07-16       Impact factor: 4.345

Review 4.  Future prospects for contact factors as therapeutic targets.

Authors:  David Gailani
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2014-11-18

Review 5.  Recent advances in the discovery and development of factor XI/XIa inhibitors.

Authors:  Rami A Al-Horani; Daniel K Afosah
Journal:  Med Res Rev       Date:  2018-05-04       Impact factor: 12.944

Review 6.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

Authors:  Daniel K Afosah; Rami A Al-Horani
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

Review 7.  The hemostatic role of factor XI.

Authors:  Cristina Puy; Rachel A Rigg; Owen J T McCarty
Journal:  Thromb Res       Date:  2016-05       Impact factor: 3.944

Review 8.  Factor XIa inhibitors: A review of the patent literature.

Authors:  Rami A Al-Horani; Umesh R Desai
Journal:  Expert Opin Ther Pat       Date:  2016       Impact factor: 6.674

Review 9.  Factor XI as a target for antithrombotic therapy.

Authors:  Charles E Bane; David Gailani
Journal:  Drug Discov Today       Date:  2014-06-02       Impact factor: 7.851

10.  Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics.

Authors:  Daniel K Afosah; Rami A Al-Horani; Nehru Viji Sankaranarayanan; Umesh R Desai
Journal:  J Med Chem       Date:  2017-01-05       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.